人工智能在结直肠癌风险预测、预后评估及治疗反应评估中的作用：现状与未来方向

Role of artificial intelligence in risk prediction, prognostication, and therapy response assessment in colorectal cancer: current state and future directions.

作者信息

Mansur Arian, Saleem Zain, Elhakim Tarig, Daye Dania

机构信息

Harvard Medical School, Boston, MA, United States.

University of Ottawa, Ottawa, ON, Canada.

出版信息

Front Oncol. 2023 Jan 25;13:1065402. doi: 10.3389/fonc.2023.1065402. eCollection 2023.

DOI:10.3389/fonc.2023.1065402

PMID:36761957

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9905815/

Abstract

Artificial Intelligence (AI) is a branch of computer science that utilizes optimization, probabilistic and statistical approaches to analyze and make predictions based on a vast amount of data. In recent years, AI has revolutionized the field of oncology and spearheaded novel approaches in the management of various cancers, including colorectal cancer (CRC). Notably, the applications of AI to diagnose, prognosticate, and predict response to therapy in CRC, is gaining traction and proving to be promising. There have also been several advancements in AI technologies to help predict metastases in CRC and in Computer-Aided Detection (CAD) Systems to improve miss rates for colorectal neoplasia. This article provides a comprehensive review of the role of AI in predicting risk, prognosis, and response to therapies among patients with CRC.

摘要

人工智能（AI）是计算机科学的一个分支，它利用优化、概率和统计方法，基于大量数据进行分析和预测。近年来，人工智能彻底改变了肿瘤学领域，并引领了各种癌症（包括结直肠癌，CRC）管理的新方法。值得注意的是，人工智能在CRC的诊断、预后评估和治疗反应预测方面的应用越来越受到关注，并被证明具有前景。在人工智能技术方面也有多项进展，以帮助预测CRC中的转移情况，以及在计算机辅助检测（CAD）系统中提高大肠肿瘤的漏诊率。本文全面综述了人工智能在预测CRC患者的风险、预后和治疗反应方面的作用。